This trial will study whether Acute normovolemic hemodilution (ANH), a blood conservation technique, can reduce transfusion in complex cardiac surgery patients. ANH has been demonstrated to reduce transfusion in lower risk cardiac surgery without any significant complications.
1 Primary · 44 Secondary · Reporting Duration: During intraoperative period
112 Total Participants · 2 Treatment Groups
Primary Treatment: Acute normovolemic hemodilution (ANH) · No Placebo Group · Phase 3
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: